ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis

    NEXT STORY
    Chembio Diagnostics Completes Acquisition of Orangelife
    PREV STORY
    FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Diffusion Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

    CHARLOTTESVILLE, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” ...

    author_avatar
    NASDAQ Market News

    Pluristem Provides Fiscal Year 2016 Corporate and Financial Highlights

    Executing an efficient commercialization strategy with  three planned late stage pivotal trials Innovative regulatory pathway ...

    author_avatar
    NASDAQ Market News

    Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors

    SAINT-GENIS-POUILLY, France, July 21, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA ...

    author_avatar
    NASDAQ Market News